Position:Home > News >

The Drug-CZ48 is in clinical trials

2018-09-21 12:33:00
  On September 21th,2018,a board meeting was held for the new drug CZ48,developed by NMT Pharmaceuticals Pte Ltd and CAO Pharmaceuticals Inc. .

  The record as bellow:CAO Pharmaceuticals Inc have finished the cohot 1 and cohot 2,and will take appropriate patients for cohot 3 as fast ad possible,
The clinical trial is expected to be completed by March 2019.
copyright©Global Unity All Rights Reserved